SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043278
Filing Date
2018-08-09
Accepted
2018-08-09 16:04:40
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499937_10q.htm 10-Q 320588
2 EXHIBIT 31.1 tv499937_ex31-1.htm EX-31.1 10590
3 EXHIBIT 31.2 tv499937_ex31-2.htm EX-31.2 10691
4 EXHIBIT 32.1 tv499937_ex32-1.htm EX-32.1 4240
5 EXHIBIT 32.2 tv499937_ex32-2.htm EX-32.2 4226
  Complete submission text file 0001144204-18-043278.txt   4132103

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abeo-20180630.xml EX-101.INS 1379037
7 XBRL TAXONOMY EXTENSION SCHEMA abeo-20180630.xsd EX-101.SCH 20507
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abeo-20180630_cal.xml EX-101.CAL 25170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abeo-20180630_def.xml EX-101.DEF 172025
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abeo-20180630_lab.xml EX-101.LAB 175837
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abeo-20180630_pre.xml EX-101.PRE 190897
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 181004995
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences